Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials

Wang, G; Ma, GS; Tao, L; Yuan, ZY; Liu, HL; Hu, XQ; Tong, Q; Yu, ZX; Zhou, XC; Han, YL

Han, YL (corresponding author), Northern Theater Command, Gen Hosp, Dept Cardiol, Shenyang 110016, Liaoning, Peoples R China.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020; 95 (): 565

Abstract

Objectives To analyze the 3-year outcomes of the biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in CREDIT II AND III TRIALS......

Full Text Link